Inhaled Iloprost and Oral Sildenafil Combination Therapy: Is it a Chance for Heart Transplant Candidacy?

This publication has 23 references indexed in Scilit:

• Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
  European Journal of Cardio-Thoracic Surgery, 2009
• Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices
  European Journal of Cardio-Thoracic Surgery, 2007
• Reversible Pulmonary Hypertension in Heart Transplant Candidates: To Transplant or Not to Transplant
  The Annals of Thoracic Surgery, 2006
• Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation
  The Journal of Heart and Lung Transplantation, 2005
• The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure
  JACC, 2004
• Effect of Inhaled Iloprost Plus Oral Sildenafil in Patients With Primary Pulmonary Hypertension
  Circulation, 2001
• Reevaluating the significance of pulmonary hypertension before cardiac transplantation: Determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality
  The Journal of Thoracic and Cardiovascular Surgery, 1997
• A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)
  American Heart Journal, 1997
• Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: Testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group
  JACC, 1992
• Ca/CaM-Stimulated and cGMP-Specific Phosphodiesterases in Vascular and Non-Vascular Tissues
  1991